Biomx Inc (PHGE) FY2025Q3 Earning Prediction
Biomx Inc (PHGE) is set to release its earnings performance on 11/12 06:30:00 ET in Pre-Market trading. Consensus forecasts predict a revenue of - and an earnings per share (EPS) of -0.32 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
PHGE Transcript
The earnings call highlighted significant financial challenges, including a substantial net loss and a declining cash balance. Despite some positive developments, such as potential DHA support and FDA feedback, the financial health concerns and lack of clear guidance on critical issues, like the nebulizer hold, overshadowed these positives. The Q&A revealed management's vague responses, especially regarding the Phase III study for BX004, contributing to uncertainty. These factors, combined with the operational reductions and financial risks, suggest a likely negative impact on the stock price.
The earnings call presents a mixed picture: positive trial results and strong interest in BX004, but with significant regulatory and market risks. Financial metrics show decreased losses and cash usage, but the net cash position is declining. The Q&A highlights enthusiasm for BX004 but also reveals management's reluctance to provide specific timelines, suggesting uncertainty. Without clear guidance or new partnerships, and considering the absence of a market cap, the stock price is likely to remain stable, leading to a neutral sentiment.
The earnings call indicates positive developments, such as ongoing clinical trials and financing to support operations until 2026. However, there are significant risks, including regulatory uncertainties and financial sufficiency concerns. The Q&A section highlighted unclear responses from management, contributing to uncertainty. Although the company is addressing unmet needs, the lack of immediate catalysts and the absence of a market cap suggest a neutral stock price movement in the short term.
The earnings call presents a mixed picture. Financially, the company has decreased its net loss and improved cash management, but there are ongoing financial challenges and reliance on external funding. Regulatory risks and competitive pressures in the DFO market remain significant concerns. The Q&A reveals some uncertainty in regulatory interactions and study designs, which could affect investor sentiment. However, the $12 million financing and non-diluted funding from the U.S. Defense Health Agency are positives. Overall, the stock price is likely to remain stable, leading to a neutral prediction.
PHGE Report
Frequently Asked Questions
What is the Biomx Inc FY2025Q3 Earnings Release Date and Time?
Biomx Inc (PHGE) is scheduled to release its FY2025Q3 earnings report onNov 12, 2025, Pre-Market(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Biomx Inc FY2025Q3 Revenue and EPS?
Analysts' consensus predicts in revenue and an EPS of -0.32 for Biomx Inc's FY2025Q3.
What Does Intellectia's AI Predict for Biomx Inc FY2025Q3 Earnings?
Intellectia's exclusive AI algorithms forecast a forBiomx Inc's FY2025Q3 earnings, with a prediction date of Nov 12, 2025. Biomx Inc
How Can I Use This Earnings Prediction to Trade PHGE Stock?
Leverage Intellectia's AI forecast to position trades ahead of theNov 12, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Biomx Inc FY2025Q3?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
